d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A phase 1, open label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function [Country] SE [Cancer type] 
Solide tumores
Nordic NECT - Inclusion completed
Cancer type